Il 2 Rbeta Selective Agonists In Combination With An Anti Ctla 4

Il 2 Rbeta Selective Agonists In Combination With An Anti Ctla 4 Antibody Or An An Anti Pd 1 Antibody

Abstract: The invention relates to (among other things) method of administering to a patient suffering from a cancer the method comprising the steps of: (a) an IL 2Rß activating amount of a long acting IL 2Rß selective agonist; and (b) a CTLA 4 pathway inhibiting amount of an anti CTLA 4 antibody or a PD 1 pathway inhibiting amount of an anti PD 1 antibody.

Patent Information

Application #

Filing Date

27 July 2016

Publication Number

36/2016

Publication Type

INA

Invention Field

PHARMACEUTICALS

Status

Email

remfry-sagar@remfry.com

Parent Application

Applicants

NEKTAR THERAPEUTICS (INDIA) PVT. LTD.

Sy. No.: 101/102, Lalgadi, Malakpet Shameerpet Mandal, Rangareddy Dist, Hyderabad - 500 078,

NEKTAR THERAPEUTICS

455 Mission Bay Blvd. South, San Francisco, CA 94158,

Inventors

1. ADDEPALLI MURALI KRISHNA

Plot #4, Jupiter Colony, Teachers colony, Secunderabad, Andhra Pradesh 500 015,

2. CHARYCH DEBORAH H.

909 Taylor Street, Albany, California 94706,

3. KANTAK SEEMA

1230 Sheila Lane, Pacifica, California-94044,

4. LEE STEVEN ROBERT

15956 East 14th Street #209, San Leandro California 94578,

Specification

SOFT COPY ATTACHED IN PDF

Documents

Orders

Section	Controller	Decision Date

Application Documents

#	Name	Date
1	Priority Document [27-07-2016(online)].pdf	2016-07-27
2	Form 5 [27-07-2016(online)].pdf	2016-07-27
3	Form 3 [27-07-2016(online)].pdf	2016-07-27
4	Form 1 [27-07-2016(online)].pdf	2016-07-27
5	Drawing [27-07-2016(online)].pdf	2016-07-27
6	Description(Complete) [27-07-2016(online)].pdf	2016-07-27
7	Form 26 [05-09-2016(online)].pdf	2016-09-05
8	201647025679.pdf	2016-09-17
9	201647025679-Power of Attorney-070916.pdf	2016-11-11
10	201647025679-Correspondence-PA-070916.pdf	2016-11-11
11	201647025679-FORM 18 [01-02-2018(online)].pdf	2018-02-01
12	201647025679-FER.pdf	2020-01-09
13	201647025679-FORM 4(ii) [03-07-2020(online)].pdf	2020-07-03
14	201647025679-RELEVANT DOCUMENTS [08-10-2020(online)].pdf	2020-10-08
15	201647025679-Proof of Right [08-10-2020(online)].pdf	2020-10-08
16	201647025679-PETITION UNDER RULE 137 [08-10-2020(online)].pdf	2020-10-08
17	201647025679-PETITION UNDER RULE 137 [08-10-2020(online)]-2.pdf	2020-10-08
18	201647025679-PETITION UNDER RULE 137 [08-10-2020(online)]-1.pdf	2020-10-08
19	201647025679-OTHERS [08-10-2020(online)].pdf	2020-10-08
20	201647025679-MARKED COPIES OF AMENDEMENTS [08-10-2020(online)].pdf	2020-10-08
21	201647025679-FORM 13 [08-10-2020(online)].pdf	2020-10-08
22	201647025679-FER_SER_REPLY [08-10-2020(online)].pdf	2020-10-08
23	201647025679-DRAWING [08-10-2020(online)].pdf	2020-10-08
24	201647025679-CORRESPONDENCE [08-10-2020(online)].pdf	2020-10-08
25	201647025679-CLAIMS [08-10-2020(online)].pdf	2020-10-08
26	201647025679-Annexure [08-10-2020(online)].pdf	2020-10-08
27	201647025679-AMMENDED DOCUMENTS [08-10-2020(online)].pdf	2020-10-08
28	201647025679-US(14)-HearingNotice-(HearingDate-25-01-2024).pdf	2023-12-22
29	201647025679-Correspondence to notify the Controller [25-01-2024(online)].pdf	2024-01-25

Search Strategy

1	searchstrategy_08-01-2020.pdf